Friday Mar 7
HIV and Hepatitis
CROI 2014: Protected T-cells Persist and Proliferate in HIV Gene Therapy Study
Genetically modified CD4 T-cells lacking CCR5 co-receptors reach high levels in the body and are resistant to HIV infection, potentially enabling people to maintain a low viral load while off antiretroviral therapy , according to the latest reports from studies evaluating Sangamo Biosciences' SB-728-T zinc finger gene therapy technology.
Chemotherapy helps HIV patients respond to Sangamo gene treatment
Treating HIV patients first with a chemotherapy drug improved their response to an experimental gene-modifying technique for fighting the virus, according to Sangamo BioSciences.
Optimal timing (Preemptive versus supportive) of granulocyte...
The aim of this study is to compare various time schedules of granulocyte colony-stimulating factor treatment in a clinical model of patients who received high-dose cyclophosphamide for the treatment of an underlying malignancy in order to investigate the optimal time of G-CSF initiation upon the incidence and duration of cytopenias and related ... (more)
A drug that can help wipe out reservoirs of cancer cells in bone marrow
Cancer drugs that recruit antibodies from the body's own immune system to help kill tumors have shown much promise in treating several types of cancer.
Researchers from Chonbuk National University Provide Details of New...
We reviewed the experiences of 10 institutions with 103 non-Hodgkin lymphoma patients who had previously only been treated with cyclophosphamide, doxorubicin, vincristine, and prednisone based chemotherapy."